Radar-Ad
Launched in January 2019, RADAR-AD - Remote Assessment of Disease and Relapse – Alzheimer’s Disease, is a collaborative research project, funded by the Innovative Medicine Initiative (IMI2). It explores the potential of mobile and digital technologies to improve the assessment of Alzheimer’s Disease (AD). It is our vision to radically improve the assessment of Alzheimer’s Disease and the care for people living with AD. We aim to do so by exploring how mobile technologies – such as smart phones, wearables and home-based sensors – can be used to measure disability progression associated with AD. RADAR-AD receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See for more details.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
51 to 200
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Radar-Ad
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Radar-Ad
1 distinct titles indexed · top 1 shown.
- 1senior project manager
Sign up to unlock all 1 contacts at Radar-Ad
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Radar-Ad
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.